Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Myelin oligodendrocyte glycoprotein (MOG) gene is associated with obsessive-compulsive disorder.

Zai G, Bezchlibnyk YB, Richter MA, Arnold P, Burroughs E, Barr CL, Kennedy JL.

Am J Med Genet B Neuropsychiatr Genet. 2004 Aug 15;129B(1):64-8.

PMID:
15274043
2.

Genetic study of the myelin oligodendrocyte glycoprotein (MOG) gene in schizophrenia.

Zai G, King N, Wigg K, Couto J, Wong GW, Honer WG, Barr CL, Kennedy JL.

Genes Brain Behav. 2005 Feb;4(1):2-9.

3.

Evidence for the gamma-amino-butyric acid type B receptor 1 (GABBR1) gene as a susceptibility factor in obsessive-compulsive disorder.

Zai G, Arnold P, Burroughs E, Barr CL, Richter MA, Kennedy JL.

Am J Med Genet B Neuropsychiatr Genet. 2005 Apr 5;134B(1):25-9.

PMID:
15685626
4.

Linkage study of polymorphisms in the gene for myelin oligodendrocyte glycoprotein located on chromosome 6p and attention deficit hyperactivity disorder.

Barr CL, Shulman R, Wigg K, Schachar R, Tannock R, Roberts W, Malone M, Kennedy JL.

Am J Med Genet. 2001 Apr 8;105(3):250-4.

PMID:
11353444
5.

Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder.

Dickel DE, Veenstra-VanderWeele J, Cox NJ, Wu X, Fischer DJ, Van Etten-Lee M, Himle JA, Leventhal BL, Cook EH Jr, Hanna GL.

Arch Gen Psychiatry. 2006 Jul;63(7):778-85.

PMID:
16818867
6.

Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder.

Arnold PD, Sicard T, Burroughs E, Richter MA, Kennedy JL.

Arch Gen Psychiatry. 2006 Jul;63(7):769-76.

PMID:
16818866
7.

The association of myelin oligodendrocyte glycoprotein gene and white matter volume in obsessive-compulsive disorder.

Atmaca M, Onalan E, Yildirim H, Yuce H, Koc M, Korkmaz S.

J Affect Disord. 2010 Aug;124(3):309-13. doi: 10.1016/j.jad.2010.03.027. Epub 2010 May 7.

PMID:
20452030
8.

5HT1Dbeta Receptor gene implicated in the pathogenesis of Obsessive-Compulsive Disorder: further evidence from a family-based association study.

Mundo E, Richter MA, Zai G, Sam F, McBride J, Macciardi F, Kennedy JL.

Mol Psychiatry. 2002;7(7):805-9.

9.

Association between the dopamine receptor D4 (DRD4) gene and obsessive-compulsive disorder.

Millet B, Chabane N, Delorme R, Leboyer M, Leroy S, Poirier MF, Bourdel MC, Mouren-Simeoni MC, Rouillon F, Loo H, Krebs MO.

Am J Med Genet B Neuropsychiatr Genet. 2003 Jan 1;116B(1):55-9.

PMID:
12497615
10.

A genetic family-based association study of OLIG2 in obsessive-compulsive disorder.

Stewart SE, Platko J, Fagerness J, Birns J, Jenike E, Smoller JW, Perlis R, Leboyer M, Delorme R, Chabane N, Rauch SL, Jenike MA, Pauls DL.

Arch Gen Psychiatry. 2007 Feb;64(2):209-14.

PMID:
17283288
11.

Linkage disequilibrium analysis of polymorphisms in the gene for myelin oligodendrocyte glycoprotein in Tourette's syndrome patients from a Chinese sample.

Huang Y, Li T, Wang Y, Ansar J, Lanting G, Liu X, Zhao JH, Hu X, Sham PC, Collier D.

Am J Med Genet B Neuropsychiatr Genet. 2004 Jan 1;124B(1):76-80.

PMID:
14681920
12.

Association between homozygosity at the COMT gene locus and obsessive compulsive disorder.

Schindler KM, Richter MA, Kennedy JL, Pato MT, Pato CN.

Am J Med Genet. 2000 Dec 4;96(6):721-4.

PMID:
11121168
13.

Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorder.

McDougle CJ, Epperson CN, Price LH, Gelernter J.

Mol Psychiatry. 1998 May;3(3):270-3.

PMID:
9672904
14.

Exploratory factor analysis of obsessive-compulsive patients and association with 5-HTTLPR polymorphism.

Cavallini MC, Di Bella D, Siliprandi F, Malchiodi F, Bellodi L.

Am J Med Genet. 2002 Apr 8;114(3):347-53.

PMID:
11920862
15.

Extensive genotyping of the BDNF and NTRK2 genes define protective haplotypes against obsessive-compulsive disorder.

Alonso P, Gratacòs M, Menchón JM, Saiz-Ruiz J, Segalàs C, Baca-García E, Labad J, Fernández-Piqueras J, Real E, Vaquero C, Pérez M, Dolengevich H, González JR, Bayés M, de Cid R, Vallejo J, Estivill X.

Biol Psychiatry. 2008 Mar 15;63(6):619-28. Epub 2007 Sep 19.

PMID:
17884018
16.

Cluster analysis of obsessive-compulsive spectrum disorders in patients with obsessive-compulsive disorder: clinical and genetic correlates.

Lochner C, Hemmings SM, Kinnear CJ, Niehaus DJ, Nel DG, Corfield VA, Moolman-Smook JC, Seedat S, Stein DJ.

Compr Psychiatry. 2005 Jan-Feb;46(1):14-9.

PMID:
15714189
17.

Mu opioid receptor gene as a candidate for the study of obsessive compulsive disorder with and without tics.

Urraca N, Camarena B, Gómez-Caudillo L, Esmer MC, Nicolini H.

Am J Med Genet B Neuropsychiatr Genet. 2004 May 15;127B(1):94-6.

PMID:
15108189
18.

The role of the brain-derived neurotrophic factor (BDNF) val66met variant in the phenotypic expression of obsessive-compulsive disorder (OCD).

Katerberg H, Lochner C, Cath DC, de Jonge P, Bochdanovits Z, Moolman-Smook JC, Hemmings SM, Carey PD, Stein DJ, Sondervan D, Boer JA, van Balkom AJ, Polman A, Heutink P.

Am J Med Genet B Neuropsychiatr Genet. 2009 Dec 5;150B(8):1050-62. doi: 10.1002/ajmg.b.30930.

PMID:
19219856
19.

Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder.

Karayiorgou M, Sobin C, Blundell ML, Galke BL, Malinova L, Goldberg P, Ott J, Gogos JA.

Biol Psychiatry. 1999 May 1;45(9):1178-89.

PMID:
10331110
20.

Association between serotonergic candidate genes and specific phenotypes of obsessive compulsive disorder.

Denys D, Van Nieuwerburgh F, Deforce D, Westenberg HG.

J Affect Disord. 2006 Mar;91(1):39-44. Epub 2006 Jan 27.

PMID:
16443280

Supplemental Content

Support Center